Teriflunomide

CAS 163451-81-8 22 current recordsSmall Molecule

Who holds supplier records for Teriflunomide? 22 organisations hold a current record for Teriflunomide: an active US FDA Type II Drug Master File or a CEP. 16 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (16), Argentina (1), Germany (1), Taiwan (1) and 3 other countries (3).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Teriflunomide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/teriflunomide

Reading the evidence

  • 22 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    16 of the 22 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 14 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Teriflunomide expires 4 Aug 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (22)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Teriflunomide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Teriflunomide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (16)

Certificates of Suitability on the EDQM register for Teriflunomide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2025-499 - Rev 00
Teriflunomide, Form-I
Oct 2026—
EMCURE PHARMACEUTICALS LIMITED PuneIN
CEP 2023-076 - Rev 01
Teriflunomide
Aug 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2023-135 - Rev 02
Teriflunomide
May 2026—
MAPRIMED S.A. Buenos AiresAR
CEP 2022-005 - Rev 01
Teriflunomide
Jul 2025Inspected Jul 2025
France
HONOUR LAB LIMITED HyderabadIN
CEP 2023-422 - Rev 00
Teriflunomide
Apr 2025—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2023-313 - Rev 00
Teriflunomide
Jan 2025—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2023-080 - Rev 01
Teriflunomide
Nov 2024—
INTAS PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2021-384 - Rev 02
Teriflunomide
Nov 2024—
MEGA FINE PHARMA PRIVATE LIMITED MumbaiIN
CEP 2022-418 - Rev 00
Teriflunomide
Sept 2024—
BIOCON LIMITED BengaluruIN
CEP 2023-134 - Rev 00
Teriflunomide
Aug 2024—
PHARMAZELL GMBH RaublingDE
CEP 2023-073 - Rev 00
Teriflunomide
Jul 2024Inspected Jun 2025
Germany
OPTIMUS DRUGS PRIVATE LIMITED HyderabadIN
CEP 2022-254 - Rev 00
Teriflunomide
Feb 2024—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2020-403 - Rev 01
Teriflunomide, Form-M
Feb 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2021-207 - Rev 02
Teriflunomide
Jan 2024—
SABA ILAC SANAYII VE TICARET A.S. IstanbulTR
R0-CEP 2021-417 - Rev 00
Teriflunomide
Aug 2023—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R0-CEP 2021-264 - Rev 00
Teriflunomide
Mar 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (28 listed products contain Teriflunomide). The latest listed patent expires 4 Aug 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Teriflunomide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL973).

Chemical identity

IUPAC name
(Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
Canonical SMILES
C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O
InChIKey
UTNUDOFZCWSZMS-YFHOEESVSA-N
Synonyms
A77 1726, Aubagio, HMR-1726, HMR1726, Leflunomide related compound b, Leflunomide related compound b rs, Teriflunomida, Teriflunomide, Teriflunomide accord, Teriflunomide mylan, Flucyamide, HMR 1726

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Pyrimidine Synthesis Inhibitor
Mechanism of action
Dihydroorotate Dehydrogenase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Teriflunomide?

22 organisations hold an active US FDA Type II Drug Master File or a CEP for Teriflunomide: Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Biocon Limited (India), Emcure Pharmaceuticals Limited (India), HONOUR LAB LTD (India), Intas Pharmaceuticals Ltd. (India) and MAPRIMED SA (Argentina), and 14 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Teriflunomide Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 28898), ALIVUS LIFE SCIENCES LTD (DMF 28991), APITORIA PHARMA PRIVATE LTD (DMF 30340), Biocon Limited (DMF 30297), Emcure Pharmaceuticals Limited (DMF 30414), HONOUR LAB LTD (DMF 29701), Intas Pharmaceuticals Ltd. (DMF 30491) and MAPRIMED SA (DMF 36622) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Teriflunomide have a European Certificate of Suitability?

Yes. 16 organisations hold a valid CEP for Teriflunomide on the EDQM register, including ZYDUS LIFESCIENCES LIMITED Vadodara (IN), EMCURE PHARMACEUTICALS LIMITED Pune (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), MAPRIMED S.A. Buenos Aires (AR), HONOUR LAB LIMITED Hyderabad (IN) and SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN) and 10 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Teriflunomide?

Yes. The latest patent listed for an approved US product containing Teriflunomide expires 4 Aug 2034, across 28 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Teriflunomide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Teriflunomide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.